Literature DB >> 9430645

p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53.

A Ori1, A Zauberman, G Doitsh, N Paran, M Oren, Y Shaul.   

Abstract

The transcription program of the hepatitis B virus (HBV) genome is regulated by an enhancer element that binds multiple ubiquitous and liver-enriched transcription activators. HBV transcription and replication are repressed in the presence of p53. Here we describe a novel molecular mechanism that is responsible for this repression. The p53 protein binds to a defined region within the HBV enhancer in a sequence-specific manner, and this, surprisingly, results in p53-dependent transcriptional repression in the context of the whole HBV enhancer. This unusual behavior of the HBV enhancer can be reconstituted by replacing its p53-binding region with the p53-binding domain of the mdm2 promoter. Remarkably, mutation of the EP element of the enhancer reversed the effect of p53 from repression to transcriptional stimulation. Furthermore, EP-dependent modulation of p53 activity can be demonstrated in the context of the mdm2 promoter, suggesting that EP is not only required but is also sufficient to convert p53 activity from positive to negative. Our results imply that the transcriptional effect of DNA-bound p53 can be dramatically modulated by the DNA context and by adjacent DNA-protein interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9430645      PMCID: PMC1170404          DOI: 10.1093/emboj/17.2.544

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  68 in total

1.  Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I.

Authors:  N Aoyama; T Nagase; T Sawazaki; G Mizuguchi; H Nakagoshi; J I Fujisawa; M Yoshida; S Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Rearrangement of the p53 gene in human osteogenic sarcomas.

Authors:  H Masuda; C Miller; H P Koeffler; H Battifora; M J Cline
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Negative regulation of Rb expression by the p53 gene product.

Authors:  Y Shiio; T Yamamoto; N Yamaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  c-abl has a sequence-specific enhancer binding activity.

Authors:  R Dikstein; D Heffetz; Y Ben-Neriah; Y Shaul
Journal:  Cell       Date:  1992-05-29       Impact factor: 41.582

5.  Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region.

Authors:  P Ostapchuk; G Scheirle; P Hearing
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

6.  Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer.

Authors:  J Honigwachs; O Faktor; R Dikstein; Y Shaul; O Laub
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

7.  Cellular factors that interact with the hepatitis B virus enhancer.

Authors:  R Ben-Levy; O Faktor; I Berger; Y Shaul
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

8.  Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.

Authors:  G P Zambetti; J Bargonetti; K Walker; C Prives; A J Levine
Journal:  Genes Dev       Date:  1992-07       Impact factor: 11.361

9.  Inhibition of viral and cellular promoters by human wild-type p53.

Authors:  M A Subler; D W Martin; S Deb
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

10.  Multiple nuclear proteins in liver cells are bound to hepatitis B virus enhancer element and its upstream sequences.

Authors:  Y Shaul; R Ben-Levy
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  24 in total

1.  The tumor suppressor p53 inhibits Net, an effector of Ras/extracellular signal-regulated kinase signaling.

Authors:  Koji Nakade; Hong Zheng; Gitali Ganguli; Gilles Buchwalter; Christian Gross; Bohdan Wasylyk
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

2.  Differential binding of NF1 transcription factor to P53 gene promoter and its depletion in human breast tumours.

Authors:  B K Nayak; B R Das
Journal:  Mol Biol Rep       Date:  1999-12       Impact factor: 2.316

3.  Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.

Authors:  Guangyan Liu; Xiancai Ma; Zhe Wang; Kousho Wakae; Yaochang Yuan; Zhangping He; Hironori Yoshiyama; Hisashi Iizasa; Hui Zhang; Mami Matsuda; Ryuichi Sugiyama; Zhiyu Yuan; Masamichi Muramatsu; Linghua Li
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

4.  p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding.

Authors:  K C Lee; A J Crowe; M C Barton
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 5.  Transcriptional regulation by p53.

Authors:  Rachel Beckerman; Carol Prives
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-28       Impact factor: 10.005

6.  p73beta inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73alpha.

Authors:  Zhen-Hua Xu; Mu-Jun Zhao; Tsai-Ping Li
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

7.  The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro.

Authors:  C T Bock; N P Malek; H L Tillmann; M P Manns; C Trautwein
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  p53 responsive elements in human retrotransposons.

Authors:  C R Harris; A Dewan; A Zupnick; R Normart; A Gabriel; C Prives; A J Levine; J Hoh
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

9.  Identification of two novel functional p53 responsive elements in the herpes simplex virus-1 genome.

Authors:  Jui-Cheng Hsieh; Ryan Kuta; Courtney R Armour; Paul E Boehmer
Journal:  Virology       Date:  2014-05-29       Impact factor: 3.616

10.  Enhancer I predominance in hepatitis B virus gene expression.

Authors:  Gilad Doitsh; Yosef Shaul
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.